1. Short bowel syndrome: influence of nutritional therapy and incretin GLP1 on bone marrow adipose tissue.
- Author
-
Parreiras-E-Silva LT, de Araújo IM, Elias J Jr, Nogueira-Barbosa MH, Suen VMM, Marchini JS, Bonella J, Nahas AK, Salmon CEG, and de Paula FJA
- Subjects
- Adipose Tissue metabolism, Adult, Bone Density, Bone Marrow metabolism, Bone Remodeling, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Osteoporosis etiology, Osteoporosis metabolism, Short Bowel Syndrome complications, Glucagon-Like Peptide 1 metabolism, Incretins metabolism, Parenteral Nutrition, Short Bowel Syndrome metabolism, Short Bowel Syndrome therapy
- Abstract
Energy deprivation leads to a decrease in white adipose tissue and bone mineral density (BMD), while simultaneously inducing the expansion of marrow adipose tissue (MAT). In short bowel syndrome (SBS), parenteral nutrition mitigates the deterioration of nutritional status, including decreases in MAT. Osteoporosis is, however, a frequent complication of SBS. The objective of our study here was to evaluate the association of fat deposit sites (subcutaneous and visceral adipose tissues: intrahepatic lipid (IHL) and MAT) and the incretin glucagon-like peptide 1 (GLP1) with BMD in individuals with SBS. MAT was negatively correlated with lumbar spine BMD in normal individuals, but not in those in the SBS group, who otherwise showed a positive correlation between MAT and GLP1. In addition, in individuals with SBS, IHL was negatively associated with lumbar spine BMD and positively associated with C-terminal telopeptide of type 1 collagen (a serum biomarker of bone turnover). Caloric maintenance in individuals with SBS, therefore, seems to positively affect the relationship between MAT and BMD, which may be modulated, at least in part, by GLP1., (© 2018 New York Academy of Sciences.)
- Published
- 2018
- Full Text
- View/download PDF